Quiros L M, Fidalgo S, Mendez F J, Hardisson C, Salas J A
Departamento de Microbiologia, Universidad de Oviedo, Spain.
Antimicrob Agents Chemother. 1988 Apr;32(4):420-5. doi: 10.1128/AAC.32.4.420.
Clinical isolates of Staphylococcus and Arthrobacter spp. were screened for lincosamide resistance. Six different patterns of resistance were found. Strains designated SF27 and SF28 showed low-level resistance to lincosamides: one was susceptible to erythromycin (SF27) and the other was resistant (SF28). Analysis of ribosomes from the resistant strains in an in vitro poly(U)-dependent protein-synthesizing system showed that ribosomes of both strains were sensitive to lincomycin and clindamycin. Four patterns of high-level resistance to lincosamides were observed (strains SF4, SF19, SF30, and SF31). All of these except SF30 had ribosomes which were highly resistant in vitro to the antibiotics and showed a close correlation with results of the in vivo experiments. In vivo protein synthesis by strain SF30 was resistant to lincomycin and sensitive to clindamycin, whereas the ribosomes were sensitive when assayed in vitro. Lincosamide-inactivating enzymes were not detected in cell extracts of the six resistant strains. Strains SF19 and SF31 demonstrated two ribosome-mediated lincosamides resistance mechanisms that were not previously reported. Both strains were highly resistant to lincosamides and susceptible to erythromycin, but SF19 was also highly resistant to oleandomycin and partially resistant to various macrolides.
对金黄色葡萄球菌和节杆菌属的临床分离株进行了林可酰胺耐药性筛查。发现了六种不同的耐药模式。命名为SF27和SF28的菌株对林可酰胺表现出低水平耐药:一株对红霉素敏感(SF27),另一株耐药(SF28)。在体外聚(U)依赖性蛋白质合成系统中对耐药菌株的核糖体进行分析表明,两株菌株的核糖体对林可霉素和克林霉素均敏感。观察到四种对林可酰胺的高水平耐药模式(菌株SF4、SF19、SF30和SF31)。除SF30外,所有这些菌株的核糖体在体外对这些抗生素高度耐药,并且与体内实验结果密切相关。菌株SF30的体内蛋白质合成对林可霉素耐药,对克林霉素敏感,而在体外检测时核糖体敏感。在这六种耐药菌株的细胞提取物中未检测到林可酰胺失活酶。菌株SF19和SF31表现出两种以前未报道过的核糖体介导的林可酰胺耐药机制。两株菌株对林可酰胺高度耐药,对红霉素敏感,但SF19对竹桃霉素也高度耐药,对各种大环内酯类药物部分耐药。